Hypoxia and HIF-1 as key regulators of gut microbiota and host interactions

被引:59
|
作者
Pral, Lais P. [1 ]
Fachi, Jose L. [1 ,2 ]
Correa, Renan O. [1 ]
Colonna, Marco [2 ]
Vinolo, Marco A. R. [1 ,3 ,4 ]
机构
[1] Univ Estadual Campinas, Inst Biol, Dept Genet & Evolut Microbiol & Immunol, Lab Immunoinflammat, Campinas, Brazil
[2] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA
[3] Expt Med Res Cluster, Campinas, Brazil
[4] Univ Estadual Campinas, Obes & Comorbid Res Ctr OCRC, Campinas, Brazil
基金
巴西圣保罗研究基金会; 美国国家卫生研究院;
关键词
INNATE LYMPHOID-CELLS; EPITHELIAL BARRIER FUNCTION; INDUCIBLE FACTOR-1-ALPHA; SMALL-INTESTINE; MOUSE MODEL; STEM-CELLS; HIF-1-ALPHA; ACTIVATION; IL-22; INTERLEUKIN-22;
D O I
10.1016/j.it.2021.05.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Oxygen (O2) availability is a key factor regulating microbiota composition and the homeostatic function of cells in the intestinal mucosa of vertebrates. Microbiotaderived metabolites increase O2 consumption by intestinal epithelial cells (IECs), reducing its availability in the gut and leading to hypoxia. This physiological hypoxia activates cellular hypoxic sensors that adapt the metabolism and function of IECs and mucosa-resident cells, such as type-3 innate lymphoid cells (ILC3s). In this review, we discuss recent evidence suggesting that the intricate and multidirectional interactions among the microbiota, hypoxia/hypoxic sensors, and mammalian host cells (IECs and ILC3s) determine how the intestinal barrier and host-microbiota-pathogens connections are molded. Understanding these interactions might provide new treatment possibilities for dysbiosis, as well as certain inflammatory and infectious diseases.
引用
收藏
页码:604 / 621
页数:18
相关论文
共 50 条
  • [31] Host-Gut Microbiota Metabolic Interactions
    Nicholson, Jeremy K.
    Holmes, Elaine
    Kinross, James
    Burcelin, Remy
    Gibson, Glenn
    Jia, Wei
    Pettersson, Sven
    [J]. SCIENCE, 2012, 336 (6086) : 1262 - 1267
  • [32] HIF-1, TGFβ3 and placental hypoxia
    Merviel, P
    [J]. NEPHROLOGIE, 2000, 21 (05): : 260 - 261
  • [33] Malaria and Gut Microbiota: Microbial Interactions in the Host
    Demirci, Mehmet
    Yildiz Zeyrek, Fadile
    [J]. MIKROBIYOLOJI BULTENI, 2022, 56 (04): : 763 - 775
  • [34] Gut microbiota-host immunomodulatory interactions
    Geva-Zatorsky, Naama
    Alvarez, David
    Hudak, Jason E.
    Mans, Nicola C. Reading
    Erturk-Hasdemir, Deniz
    Dasgupta, Suryasarathi
    von Andrian, Ulrich
    Kasper, Dennis
    [J]. CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
  • [35] Hepatocyte specific deletion of HIF-1α affects gut microbiota composition in HFD fed mice
    Luo, Beibei
    Xiang, Dao
    Wu, Die
    Chen, Peijie
    Hu, Yiping
    [J]. FASEB JOURNAL, 2018, 32 (01):
  • [36] Hypoxia inducible factor 1 (HIF-1) and cardioprotection
    Tekin, Demet
    Dursun, Ali D.
    Xi, Lei
    [J]. ACTA PHARMACOLOGICA SINICA, 2010, 31 (09) : 1085 - 1094
  • [37] Hypoxia and the hypoxia-regulated transcription factor HIF-1 suppress the host defence of airway epithelial cells
    Polke, Markus
    Seiler, Frederik
    Lepper, Philipp M.
    Kamyschnikow, Andreas
    Langer, Frank
    Monz, Dominik
    Herr, Christian
    Bals, Robert
    Beisswenger, Christoph
    [J]. INNATE IMMUNITY, 2017, 23 (04) : 373 - 380
  • [38] Vitamin B12 ameliorates gut epithelial injury via modulating the HIF-1 pathway and gut microbiota
    Feng, Chenxi
    Yan, Jinhua
    Luo, Ting
    Zhang, Hong
    Zhang, Hu
    Yuan, Yu
    Chen, Yi
    Chen, Haiyang
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2024, 81 (01)
  • [39] Hypoxia-induced activation of HIF-1, role of HIF-1α-Hsp90 interaction
    Minet, E
    Mottet, D
    Michel, G
    Roland, I
    Raes, M
    Remacle, J
    Michiels, C
    [J]. FEBS LETTERS, 1999, 460 (02) : 251 - 256
  • [40] Expression of hypoxia inducible factor 1α (HIF-1α) in the progression to oesophageal adenocarcinoma:: A key target for therapy
    Teratani, Naoki
    Nicholson, Anna M.
    Atherfold, Paul A.
    Milicic, Anita
    Jankowski, Janusz A.
    [J]. GASTROENTEROLOGY, 2008, 134 (04) : A441 - A441